March 6, 2012

The Alzheimer's Drug Pipeline - Dr. Jeffrey Cummings

Thumbnail

The Alzheimer's Drug Pipeline - Dr. Jeffrey Cummings

About This Episode

Understanding — and accelerating — the drug pipeline is crucial to efforts to stop Alzheimer’s, whether you are a policymaker, work in Alzheimer’s research or care, or are one of the thousands of grassroots advocates across the nation. Click play to listen to a recording of this call that took place on Tuesday, March 6th.

This call was made possible by the generous donation of Shawn Taylor, trustee of KPB Corporation, whose mother has Alzheimer’s and maternal grandpareAnts died of this horrible disease.

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW